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GENERAL COMMENTS
The manuscript deals on an interesting topic for cardiologists, epidemiologists and decision-makers. The CVDs are growing in an epidemic way and mainly in the LMIC. Therefore, the present work is important for the medical community. In general is well written and the results are presented clearly. However, there are minor aspects that should be addressed by the authors: Discussion: -The first paragraph is too long. It is not necessary to copy all the results, only the more significant ones.
-It would be nice to discuss why the authors think is the possible explanation for more MACE in stable than in ACS patients, taking into account that in the last the guideline treatment with early reperfusion is so delayed.
-Page 13: Why to sign a written informed consent is included among the limitations? -I would suggest putting each real limitation in a separate line to present them in a more comprehensive way. Conclusions Should be more concrete, not the repetition of the main results. Tables  I would suggest including MACE among the tables of the main paper, not in the supplementary material, due to the importance for the objectives of the present research.
VERSION 1 -AUTHOR RESPONSE

REVIEWERS' COMMENTS TO AUTHOR:
REVIEWER: 1
Reviewer Name: Jomme Claes Institution and Country: KU Leuven, Belgium
Competing Interests: None declared This is a relatively simple, but well described study. The importance of assessing the current situation
should not be underestimated with regards to developing strategies to increase healthcare practices.
The manuscript reads easy and clearly compares the current situation with other parts of the world.
I have some minor questions and language issues.
1. Page 11, line 21-26: You indicate that the stay in the hospital was short because patients returned to the referring hospital after an intervention. Was it not possible to include the length of stay in the referring hospital also? Or did you already include this stay? In that case please change the wording so it becomes more clear.
RESPONSE:
In the present study, we included 70 referred patients from other hospitals or clinics: 20 (28.6%) patients with acute coronary syndrome (ACS) and 50 (71.4%) with stable coronary artery disease (SCAD). Referred patients with SCAD underwent an elective cardiac catheterization or percutaneous coronary intervention (PCI), and were then immediately returned to their referring hospitals. Therefore, in our cohort, the time interval from admission to intervention and length of stays were considerably shorter in SCAD than ACS group. Due to lack of resources, we could not track and record the length of hospitalization in the referring hospitals. However, we believe that the duration of stay of these patients in their origin hospital would be relatively as short as we reported in this study, considering the stable condition and the elective interventions they had. We have now clarified this issue in the discussion.
The amended manuscript now reads (page 12, lines 19-27):
The time lapse from admission to intervention and length of stays were remarkably shorter in SCAD than in ACS group, because in our study the majority of referred patients (n=50, 71.4%)
were classified as SCAD. These patients underwent an elective cardiac catheterization and/or PCI and were then immediately returned to the referring hospitals. We did not track and record the duration of stay in the original hospitals. However, we assumed hospital stay duration in the referring hospitals to be relatively short because these patients usually underwent elective interventions for stable coronary artery disease.
2. In general you indicate very well the more severe symptoms of the ACS group when you compare it to other parts of the world. However, the more severe symptoms/lifestyle of the ACS group (higher fasting glucose, higher current smoking, more heart failure symptoms,...) compared to the SCAD group could also contribute to the differences seen between these two groups. For me the comparison between these two groups is not very noticeable in the discussion.
We appreciate this comment, and we do very much agree that the worse clinical profiles/symptoms and poorer lifestyles at admission presented by ACS patients were most likely associated with the poorer clinical outcomes experienced by these patients during hospitalization and after discharge compared to the patients with SCAD. We have now addressed the comparison between ACS and SCAD groups in terms of clinical profiles and lifestyles and the effect on their outcomes in the discussion.
The amended manuscript now reads (page 10, lines 28-32 and page 11, lines 1-3):
At baseline, compared to SCAD, patients with ACS were younger, had higher plasma glucose and LDL-cholesterol, had lower income and educational level, were more often current smoker, and had poorer dietary habits. Further, we observed considerably more ACS patients with diagnosis/signs of heart failure, with left ventricle hypertrophy (LVH), and with lower LVEF than SCAD patients. Likely as a result, those with ACS had poorer clinical outcomes mainly during hospitalization and at 30-day follow-up compared to those with SCAD.
3. Language: In general the manuscript is well written, but I would recommend proofreading once more. Often, prepositions like "a", "the" etc. are forgotten.
We thank the reviewer for these detailed corrections. As suggested, we have proofread our revised manuscript. The final revised draft has been circulated and approved by all authors before submission.
Some examples:
Page 4, line 28: "coronary coronary"
The amended manuscript now reads (page 4, lines 22-24):
-We excluded all patients with normal coronary angiography, and therefore our study might overlook the minor group of non-obstructive CAD.
Page 5, line 7: ... and 40% of global poor -(This sentence looks unfinished)
The amended manuscript now reads (page 5, lines 2-3):
The South-East Asia region, which accounts for one-quarter of the world's population and 40% of the global poor, is facing a rapid epidemiologic transition. However, half of these cardiologists work on Java island and in the big cities, leaving other regions even less well served.
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Page 7, line 47: FROM where the patients WERE admitted
The amended manuscript now reads (page 7, line 33 and page 8, lines 1-2):
For referred patients, we obtained data on in-hospital mortality from their family members and this was confirmed with hospital medical records from where the patients were admitted (n = 1).
The CVDs are growing in an epidemic way and mainly in the LMIC. Therefore, the present work is important for the medical community. In general is well written and the results are presented clearly.
However, there are minor aspects that should be addressed by the authors:
Discussion:
1. The first paragraph is too long. It is not necessary to copy all the results, only the more significant ones.
RESPONSE:
We agree with the reviewer, the first paragraph of discussion has now been revised as suggested.
The amended manuscript now reads (page 10, lines 19-27):
Discussion
The present study shows that CAD patients in Indonesia are predominantly young males with high prevalence of cardiovascular risk factors. More than half of this cohort had metabolic syndrome and prior hypertension; and approximately one-third had prior MI and diabetes mellitus. The majority came from rural areas with a low or middle socio-economic status, and had a history of smoking. These CAD patients showed relatively severe illness, had significant time delay from angina onset to admission or intervention, and rarely received the guidelinesrecommended treatment.
2. It would be nice to discuss why the authors think is the possible explanation for more MACE in stable than in ACS patients, taking into account that in the last the guideline treatment with early reperfusion is so delayed.
RESPONSE:
This is an important point and we thank the reviewer for highlighting this. We have now addressed this issue in the discussion.
The amended manuscript is now as follows (page 11, lines 4-15):
In contrast, at 6-month follow-up, more patients with SCAD had adverse cardiac events (p=0.043) compared to ACS. The most likely explanation is that these SCAD patients were undertreated for secondary prevention and aftercare management. Out of 113 SCAD patients, 34
(30.1%) were admitted for congestive heart failure (CHF); and of 90 SCAD patients with cardiac catheterization, 58 (64.4%) had multivessel CAD. Of those, only 32 (55.2%) underwent elective PCI. Therefore, the lack access or adherence to the guidelines-recommended treatment (i.e.
elective PCI or CABG) and the lack of engagement to the long-term cardiovascular medications might largely contribute to these poorer outcomes. Meanwhile, in ACS, low access to an early invasive strategy was more likely to be associated with the high incidence of short-term death, chiefly in the first 30 days since admission.
3. Page 13: Why to sign a written informed consent is included among the limitations?
We agree with the reviewer. As suggested, we have now restating the sentence to get rid of the ambiguous definition from our previous statement.
The amended manuscript now reads (page 15, lines 3-6):
 We had to exclude all patients who immediately died at emergency department and cardiovascular intensive care unit because we could not obtain a written informed consent from this group with the most critically ill conditions. 4. I would suggest putting each real limitation in a separate line to present them in a more comprehensive way.
As the reviewer recommended, we have put the strengths and limitations of this study in separate lines.
The amended manuscript now reads (page 15, lines 1-22):
Strengths and limitations
There are some strengths and limitations in the present study:
 We had to exclude all patients who immediately died at emergency department and cardiovascular intensive care unit because we could not obtain a written informed consent from this group with the most critically ill conditions.  The majority of our patients (51.8%) were living in rural, often very-remote areas. Hence, it
was not possible to interview all patients by means of a face-to-face interview for follow-up.
In 239 (50.1%) patients, phone-calls were used, which may have led to less accurate data than obtained by direct questionnaire-interview. However, we always verified the answers at the next visits or phone-calls with a different interviewer to reduce inaccuracies.
 We excluded all patients with normal coronary angiography, which were mostly females.
Thus, our study may have overlooked the minor group of myocardial infarction with no obstructive coronary atherosclerosis (MINOCA).
 Our study is, to our knowledge, the first in Indonesia with regard to clinical outcomes of hospitalized CAD patients. Thus, we consider our study a quite unique effort to properly report on characteristics at admission and on short-and mid-term outcomes in an attempt to identify opportunities to improve care.
Conclusions:
Should be more concrete, not the repetition of the main results.
RESPONSE:
We thank the reviewer for this comment. We have revised the conclusions as suggested.
The amended manuscript now reads (page 15, lines 24-31 and page 16, lines 1-2):
Conclusions
Patients with CAD from a poor South-East Asian setting present themselves with predominantly unstable conditions of premature CAD. These patients show relatively severe illness, have significant time delay from symptom onset to admission or intervention, and most do not receive the guidelines-recommended treatment. Awareness of symptoms, prompt initial management of acute CVD, well-established infrastructures, and resources both in primary and secondary hospital for CVD should be improved to reduce the high rates of 30-day and 6-month mortality and adverse outcomes in this population.
Tables:
I would suggest including MACE among the tables of the main paper, not in the supplementary material, due to the importance for the objectives of the present research.
RESPONSE:
We agree with the reviewer. The MACE The amended manuscript now reads (page 9, line 32 and page 10, lines 1-2):
A detailed description of MACE at 30 days and 6 months of these CAD patients is presented in Table 4 .
Page 9, lines 9-10:
Description of the most notable complaints or symptoms reported by all survivors is provided as supplement.
The added table is now as follows (Table 4 , page 25):
FORMATTING AMENDMENTS (if any)
Required amendments will be listed here; please include these changes in your revised version:
1. Supplementary File format -Please re-upload your supplementary files in PDF format. Values are n (%).
MACE, major adverse cardiovascular events; MI, myocardial infarction; HF, heart failure; CABG, coronary artery bypass graft surgery; PCI, percutaneous coronary intervention; CAG, coronary angiography.
